Efficacy and Safety of Switching from Low-Dose Statin to High-Intensity Statin for Primary Prevention in Type 2 Diabetes: A Randomized Controlled Trial
Nuntakorn Thongtang, Jirasak Piyapromdee, Natthakan Tangkittikasem, Kittichai Samaithongcharoen, Nithiwat Srikanchanawat, Sutin Sriussadaporn Division of Endocrinology and Metabolism, Department of Medicine, Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok, ThailandCorrespondence: N...
Enregistré dans:
Auteurs principaux: | Thongtang N, Piyapromdee J, Tangkittikasem N, Samaithongcharoen K, Srikanchanawat N, Sriussadaporn S |
---|---|
Format: | article |
Langue: | EN |
Publié: |
Dove Medical Press
2020
|
Sujets: | |
Accès en ligne: | https://doaj.org/article/39eb2b7810c149ce9955e1487e169e7f |
Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|
Documents similaires
-
Association of Contemporary Statin Pretreatment Intensity and LDL-C Levels on the Incidence of STEMI Presentation
par: Ziv Dadon, et autres
Publié: (2021) -
Statin Use and Adverse Effects Among Adults >75 Years of Age: Insights From the Patient and Provider Assessment of Lipid Management (PALM) Registry
par: Michael G. Nanna, et autres
Publié: (2018) -
Determinants of Statin Initiation Among Adult Diabetic Patients in Bonga, Ethiopia
par: Kebede zelalem B, et autres
Publié: (2020) -
Clinical utility of rosuvastatin and other statins for cardiovascular risk reduction among the elderly
par: Sydney B Long, et autres
Publié: (2010) -
Statins in the primary prevention of cardiovascular disease. Rosuvastatin capabilities
par: Marina G. Bubnova, et autres
Publié: (2021)